Current Neuro-Oncology




Volume 22 Number 22
30 November 2020




Home > Publications > Current Neuro-Oncology > Volume 22, Year 2020 > Number 22, 30 November






Curtin L, Whitmire P, Rickertsen CR, Mazza GL, Canoll P, Johnston SK, Mrugala MM, Swanson KR, Hu LS.
Assessment of Prognostic Value of Cystic Features in Glioblastoma Relative to Sex and Treatment With Standard-of-Care.
Front Oncol. 2020 Nov 16, 2020;10:580750
. doi: 10.3389/fonc.2020.580750. PMID: 33282737. Observational study. ˍ




Nayak L, Molinaro AM, Peters KB, Clarke JL, Jordan JT, de Groot JF, Nghiemphu PL, Kaley TJ, Colman H, McCluskey C, Gaffey S, Smith T, Cote DJ, Severgnini M, Yearley JH, Zhao Q, Blumenschein WM, Duda DG, Muzikansky A, Jain RK, Wen PY, Reardon DA.
Randomized phase II and biomarker study of pembrolizumab plus bevacizumab versus pembrolizumab alone for recurrent glioblastoma patients.
Clin Cancer Res. 2020 Nov 16, 2021;27(4):1048-1057. doi: 10.1158/1078-0432.CCR-20-2500. PMID: 33199490. Interventional study. ˍ




Sui L, Li Y, Xu Z, Shen X.
Therapeutic effect of thalidomide combined with temozolomide and three-dimensional conformal radiotherapy for patients with high-grade gliomas after operation.
J BUON. 2020 Nov 16, 2020 Nov-Dec;25(6):2608-2615
. PMID: 33455103. Observational study. ˍ




Topkan E, Kucuk A, Ozdemir Y, Mertsoylu H, Besen AA, Sezen D, Bolukbasi Y, Pehlivan B, Selek U.
Systemic Inflammation Response Index Predicts Survival Outcomes in Glioblastoma Multiforme Patients Treated with Standard Stupp Protocol.
J Immunol Res. 2020 Nov 16, 2020;2020:8628540
. doi: 10.1155/2020/8628540. PMID: 33274245. Observational study. ˍ



*

Wu B, Wang W, Wang H, Zou Q, Hu B, Ye L, Hu Y, Xie Y, Huang N, Lan Q, Cheng H, Dong J, Dai X.
Single-Cell Sequencing of Glioblastoma Reveals Central Nervous System Susceptibility to SARS-CoV-2.
Front Oncol. 2020 Nov 16;10:566599
. doi: 10.3389/fonc.2020.566599. PMID: 33312949. Laboratory investigation. ˍ




Bumes E, Wirtz FP, Fellner C, Grosse J, Hellwig D, Oefner PJ, Häckl M, Linker R, Proescholdt M, Schmidt NO, Riemenschneider MJ, Samol C, Rosengarth K, Wendl C, Hau P, Gronwald W, Hutterer M.
Non-Invasive Prediction of IDH Mutation in Patients with Glioma WHO II/III/IV Based on F-18-FET PET-Guided In Vivo 1H-Magnetic Resonance Spectroscopy and Machine Learning.
Cancers (Basel). 2020 Nov 17, 2020;12(11):3406. doi: 10.3390/cancers12113406. PMID: 33212941. Observational study. ˍ




Gao Y, Xiao X, Han B, Li G, Ning X, Wang D, Cai W, Kikinis R, Berkovsky S, Di Ieva A, Zhang L, Ji N, Liu S.
Deep Learning Methodology for Differentiating Glioma Recurrence From Radiation Necrosis Using Multimodal Magnetic Resonance Imaging: Algorithm Development and Validation.
JMIR Med Inform. 2020 Nov 17, 2020;8(11):e19805. doi: 10.2196/19805. PMID: 33200991. Observational study. ˍ




Gerstner ER, Emblem KE, Yen YF, Dietrich J, Jordan JT, Catana C, Wenchin KL, Hooker JM, Duda DG, Rosen BR, Kalpathy-Cramer J, Jain RK, Batchelor TT.
Vascular dysfunction promotes regional hypoxia after bevacizumab therapy in recurrent glioblastoma patients.
Neurooncol Adv. 2020 Nov 17, 2020;2(1):vdaa157
. doi: 10.1093/noajnl/vdaa157. PMID: 33392506. Observational study. ˍ




Ahmadipour Y, Rauschenbach L, Santos A, Darkwah Oppong M, Lazaridis L, Quesada CM, Junker A, Pierscianek D, Dammann P, Wrede KH, Scheffler B, Glas M, Stuschke M, Sure U, Jabbarli R.
Preoperative and early postoperative seizures in patients with glioblastoma-two sides of the same coin?
Neurooncol Adv. 2020 Nov 18, 2021;3(1):vdaa158
. doi: 10.1093/noajnl/vdaa158. PMID: 33506201. Observational study. ˍ




Labuschagne JJ.
The Use of 5-Aminolevulinic Acid to Assist Gross Total Resection of Paediatric Posterior Fossa Tumours.
Pediatr Neurosurg. 2020 Nov 18, 2020;55(5):268-279. doi: 10.1159/000511289. PMID: 33207361. Observational study. ˍ




Gestrich CK, Jajosky AN, Elliott R, Stearns D, Sadri N, Cohen ML, Couce ME.
Molecular Profiling of Pediatric and Adult Glioblastoma.
Am J Clin Pathol. 2020 Nov 19, 2021;155(4):606-614. doi: 10.1093/ajcp/aqaa172. PMID: 33210143. Laboratory investigation. ˍ




van Kessel E, Huenges Wajer IMC, Ruis C, Seute T, Fonville S, De Vos FYFL, Verhoeff JJC, Robe PA, van Zandvoort MJE, Snijders TJ.
Cognitive impairments are independently associated with shorter survival in diffuse glioma patients.
J Neurol. 2020 Nov 19, 2021;268(4):1434-1442. doi: 10.1007/s00415-020-10303-w. PMID: 33211158. Observational study. ˍ




Eisenhut F, Schmidt MA, Putz F, Lettmaier S, Fröhlich K, Arinrad S, Coras R, Luecking H, Lang S, Fietkau R, Doerfler A.
Classification of Primary Cerebral Lymphoma and Glioblastoma Featuring Dynamic Susceptibility Contrast and Apparent Diffusion Coefficient.
Brain Sci. 2020 Nov 20, 2020;10(11):886. doi: 10.3390/brainsci10110886. PMID: 33233698. Observational study. ˍ




Suwala AK, Stichel D, Schrimpf D, Kloor M, Wefers AK, Reinhardt A, Maas SLN, Kratz CP, Schweizer L, Hasselblatt M, Snuderl M, Abedalthagafi MSJ, Abdullaev Z, Monoranu CM, Bergmann M, Pekrun A, Freyschlag C, Aronica E, Kramm CM, Hinz F, Sievers P, Korshunov A, Kool M, Pfister SM, Sturm D, Jones DTW, Wick W, Unterberg A, Hartmann C, Dodgshun A, Tabori U, Wesseling P, Sahm F, von Deimling A, Reuss DE.
Primary mismatch repair deficient IDH-mutant astrocytoma (PMMRDIA) is a distinct type with a poor prognosis.
Acta Neuropathol. 2020 Nov 20, 2021;141(1):85-100. doi: 10.1007/s00401-020-02243-6. PMID: 33216206. Laboratory investigation. ˍ




Feng Y, Li G, Shi Z, Yan X, Wang Z, Jiang H, Chen Y, Li R, Zhai Y, Chang Y, Zhang W, Yuan F.
A novel methylation signature predicts radiotherapy sensitivity in glioma.
Sci Rep. 2020 Nov 23, 2020;10(1):20406. doi: 10.1038/s41598-020-77259-9. PMID: 33230136. Observational study. ˍ




Hidaka K, Fukushima H, Hosaka S, Muroi A, Yamamoto T, Mizumoto M, Sakurai H, Takada H.
Cognitive Functions of Pediatric Brain Tumor Survivors Treated With Proton Beam Therapy: A Case Series.
J Pediatr Hematol Oncol. 2020 Nov 23, 2021;43(8):e1205-e1209. doi: 10.1097/MPH.0000000000002011. PMID: 33235149. Case report˰ ˍ




Lee J, Wang N, Turk S, Mohammed S, Lobo R, Kim J, Liao E, Camelo-Piragua S, Kim M, Junck L, Bapuraj J, Srinivasan A, Rao A.
Discriminating pseudoprogression and true progression in diffuse infiltrating glioma using multi-parametric MRI data through deep learning.
Sci Rep. 2020 Nov 23, 2020;10(1):20331. doi: 10.1038/s41598-020-77389-0. PMID: 33230285. Observational study. ˍ




Lin Z, Xu H, Yang R, Li Z, Zheng H, Zhang Z, Peng J, Zhang X, Qi S, Liu Y, Huang G.
Effective treatment of a BRAF V600E-mutant epithelioid glioblastoma patient by vemurafenib: a case report.
Anticancer Drugs. 2021 Jul 4, 2022;33(1):100-104
. doi: 10.1097/CAD.0000000000001130. PMID: 34232949. Case report˰ ˍ
Res Square. 2020 Nov 23 [posted preprint]
ˍ. ˍ




Liu KX, Ioakeim-Ioannidou M, Susko MS, Rao AD, Yeap BY, Snijders AM, Ladra MM, Vogel J, Zaslowe-Dude C, Marcus KJ, Yock TI, Grassberger C, Braunstein SE, Haas-Kogan DA, Terezakis SA, MacDonald SM.
A Multi-institutional Comparative Analysis of Proton and Photon Therapy-Induced Hematologic Toxicity in Patients With Medulloblastoma.
Int J Radiat Oncol Biol Phys. 2020 Nov 23, 2021;109(3):726-735
. doi: 10.1016/j.ijrobp.2020.09.049. PMID: 33243479. Observational study˰ ˍ




Mao J, Zeng W, Zhang Q, Yang Z, Yan X, Zhang H, Wang M, Yang G, Zhou M, Shen J.
Differentiation between high-grade gliomas and solitary brain metastases: a comparison of five diffusion-weighted MRI models.
BMC Med Imaging. 2020 Nov 23, 2020;20(1):124. doi: 10.1186/s12880-020-00524-w. PMID: 33228564. Observational study. ˍ




Roux C, Revon-Rivière G, Gentet JC, Verschuur A, Scavarda D, Saultier P, Appay R, Padovani L, André N.
Metronomic Maintenance With Weekly Vinblastine After Induction With Bevacizumab-Irinotecan in Children With Low-grade Glioma Prevents Early Relapse.
J Pediatr Hematol Oncol. 2020 Nov 23, 2021;43(5):e630-e634. doi: 10.1097/MPH.0000000000002002. PMID: 33235152. Observational study˰ ˍ




Jaspers JPM, Méndez Romero A, Wiggenraad R, Compter I, Eekers DBP, Nout RMD, van den Bent M.
Pattern of failure in IDH mutated, low grade glioma after radiotherapy - Implications for margin reduction.
Radiother Oncol. 2020 Nov 24, 2021;156:43-48. doi: 10.1016/j.radonc.2020.11.019. PMID: 33245948. Observational study. ˍ




Hao M, Hou S, Li W, Li K, Xue L, Hu Q, Zhu L, Chen Y, Sun H, Ju C, Zhang C.
Combination of metabolic intervention and T cell therapy enhances solid tumor immunotherapy.
Sci Transl Med. 2020 Nov 25, 2020;12(571):eaaz6667. doi: 10.1126/scitranslmed.aaz6667. PMID: 33239389. Laboratory investigation. ˍ



*

Iorgulescu JB, Gokhale PC, Speranza MC, Eschle BK, Poitras MJ, Wilkens MK, Soroko KM, Chhoeu C, Knott A, Gao Y, Lim-Fat MJ, Baker GJ, Bonal DM, Nguyen QD, Grant GRL, Ligon KL, Sorger PK, Chiocca EA, Anderson AC, Kirschmeier PT, Sharpe AH, Freeman GJ, Reardon DA.
Concurrent Dexamethasone Limits the Clinical Benefit of Immune Checkpoint Blockade in Glioblastoma.
Clin Cancer Res. 2020 Nov 25, 2021;27(1):276-287. doi: 10.1158/1078-0432.CCR-20-2291. PMID: 33239433. Observational study. ˍ




Hanyu T, Fujitani S, Ito A, Mizutani N.
Brain metastasis from extramammary Paget's disease.
Nagoya J Med Sci. 2020 Nov 26, 2020 Nov;82(4):791-798
. doi: 10.18999/nagjms.82.4.791. PMID: 33311809. Case report. ˍ




Steidl E, Langen KJ, Hmeidan SA, Polomac N, Filss CP, Galldiks N, Lohmann P, Keil F, Filipski K, Mottaghy FM, Shah NJ, Steinbach JP, Hattingen E, Maurer GD.
Sequential implementation of DSC-MR perfusion and dynamic [18F]FET PET allows efficient differentiation of glioma progression from treatment-related changes.
Eur J Nucl Med Mol Imaging. 2020 Nov 26, 2021;48(6):1956-1965. doi: 10.1007/s00259-020-05114-0. PMID: 33241456. Observational study. ˍ




Decuyper M, Bonte S, Deblaere K, Van Holen R.
Automated MRI based pipeline for segmentation and prediction of grade, IDH mutation and 1p19q co-deletion in glioma.
Comput Med Imaging Graph. 2020 Nov 27, 2021 Mar;88:101831
. doi: 10.1016/j.compmedimag.2020.101831. PMID: 33482430. Observational study. ˍ




Feng Q, Li L, Li M, Wang X.
Immunological classification of gliomas based on immunogenomic profiling.
J Neuroinflammation. 2020 Nov 27, 2020;17(1):360. doi: 10.1186/s12974-020-02030-w. PMID: 33246490. Laboratory investigation. ˍ



*

Niu X, Yang Y, Zhou X, Zhang H, Zhang Y, Liu Y, Qing M.
A prognostic nomogram for patients with newly diagnosed adult thalamic glioma in a surgical cohort.
Neuro Oncol. 2020 Nov 27, 2021;23(2):337-338. doi: 10.1093/neuonc/noaa268. PMID: 33244611. Observational study. ˍ




Pinto G, Saenz-de-Santa-Maria I, Chastagner P, Perthame E, Delmas C, Toulas C, Moyal-Jonathan-Cohen E, Brou C, Zurzolo C.
Patient-derived glioblastoma stem cells transfer mitochondria through tunneling nanotubes in tumor organoids.
Biochem J. 2020 Nov 27, 2021;478(1):21-39
. doi: 10.1042/BCJ20200710. PMID: 33245115. Laboratory investigation. ˍ




Ayasoufi K, Pfaller CK, Evgin L, Khadka RH, Tritz ZP, Goddery EN, Fain CE, Yokanovich LT, Himes BT, Jin F, Zheng J, Schuelke MR, Hansen MJ, Tung W, Parney IF, Pease LR, Vile RG, Johnson AJ.
Brain cancer induces systemic immunosuppression through release of non-steroid soluble mediators.
Brain. 2020 Nov 30, 2020;143(12):3629-3652. doi: 10.1093/brain/awaa343. PMID: 33253355. Laboratory investigation. ˍ




Goldman DA, Reiner AS, Diamond EL, DeAngelis LM, Tabar V, Panageas KS.
Lack of survival advantage among re-resected elderly glioblastoma patients: a SEER-Medicare study.
Neurooncol Adv. 2020 Nov 29, 2021;3(1):vdaa159
. doi: 10.1093/noajnl/vdaa159. PMID: 33506202. Observational study. ˍ